AMP-Deoxynojirimycin

AMP-Deoxynojirimycin
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
Cay10010332-500 500 µg -

5 - 10 Werktage*

43,00 €
Cay10010332-1 1 mg -

5 - 10 Werktage*

82,00 €
Cay10010332-5 5 mg -

5 - 10 Werktage*

340,00 €
Cay10010332-10 10 mg -

5 - 10 Werktage*

595,00 €
 
The lipid messenger ceramide is converted to glucosylceramide by glucosylceramide synthase (GCS).... mehr
Produktinformationen "AMP-Deoxynojirimycin"
The lipid messenger ceramide is converted to glucosylceramide by glucosylceramide synthase (GCS). In the reverse direction, non-lysosomal glucosylceramidase (GCase), also known as beta-glucosidase 2 (BGD), cleaves the glucosyl moiety from glucosylceramide, liberating ceramide, which can be converted into sphingomyelin. AMP-deoxynojirimycin (AMP-dNM) is a hydrophobic derivative of dNM. It potently inhibits BGD (IC50 = 0.3 nM), less potently antagonizes GCS (IC50 = 25 nM), but only poorly inhibits other GCase isoforms. AMP-dNM has been shown to strongly suppress inflammation in a murine model of hapten-induced colitis, enhance insulin sensitivity in murine and rat models of insulin resistance, and induce sterol regulatory element-binding protein-regulated gene expression and cholesterol synthesis in HepG2 cells. Formal Name: 2R-(hydroxymethyl)-1-[5-(tricyclo[3.3.2.13,7]dec-1-ylmethoxy)pentyl]-3R,4R,5S-piperidinetriol. CAS Number: 216758-20-2. Synonyms: Adamantane-pentyl-dNM, AMP-dNM, N-(5-adamantane-1-yl-methoxy-pentyl)-Deoxynojirimycin. Molecular Formula: C22H39NO5. Formula Weight: 397.6. Purity: >95%. Formulation: A solution in ethanol. Solubility: DMF: 50 mg/ml, DMSO: 50 mg/ml, Ethanol: 30 mg/ml, Ethanol:PBS(pH 7.2) (1:1): 0.5 mg/ml. SMILES: OC[C@H]1N(CCCCCOCC23CC4CC(CC(C4)C3)C2)C[C@H](O)[C@@H](O)[C@@H]1O. InChi Code: InChI=1S/C22H39NO5/c24-13-18-20(26)21(27)19(25)12-23(18)4-2-1-3-5-28-14-22-9-15-6-16(10-22)8-17(7-15)11-22/h15-21,24-27H,1-14H2/t15-,16+,17-,18-,19+,20-,21-,22?/m1/s1. InChi Key: XVYLNHVEAOOEGI-OIPNBASOSA-N.
Schlagworte: Adamantane-pentyl-dNM, AMP-dNM, N-(5-adamantane-1-yl-methoxy-pentyl)-Deoxynojirimycin, 2R-(hydroxymethyl)-1-[5-(tricyclo[3.3.2.13,7]dec-1-ylmethoxy)pentyl]-3R,4R,5S-piperidinetriol
Hersteller: Cayman Chemical
Hersteller-Nr: 10010332

Eigenschaften

Anwendung: Glucosylceramide synthase inhibitor
MW: 397.6 D
Formel: C22H39NO5
Reinheit: >95%
Format: Solution

Datenbank Information

CAS : 216758-20-2| Finde Alternativen
KEGG ID : K00720 | Finde Alternativen

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +20°C (International: -20°C)
Signalwort: Danger
GHS-Piktogramme:
H-Sätze: H225
P-Sätze: P210, P233, P240, P241, P242, P243, P280, P303+361+353, P370+378, P403+235, P501
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier folgen Informationen zur Produktreferenz. mehr
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "AMP-Deoxynojirimycin"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen